Parameter | Overall survival | |||||
---|---|---|---|---|---|---|
Univariate Cox analysis | Multivariate Cox analysis | |||||
HR | 95% CI | p value | HR | 95% CI | p value | |
Age | ||||||
 ≤ 50 years | 4.172 | 1.673–10.402 | 0.002 | 3.767 | 1.500–9.461 | 0.005 |
 > 50 years |  |  |  |  |  |  |
Tumour grade | ||||||
 G1 | 1.235 | 0.887–1.719 | 0.212 |  |  |  |
 G2 |  |  |  |  |  |  |
 G3 |  |  |  |  |  |  |
Tumour size | ||||||
 pT1 | 1.028 | 1.010–1.045 | 0.002 | 2.012 | 1.469–2.754 | < 0.0001 |
 pT2 |  |  |  |  |  |  |
 pT3 |  |  |  |  |  |  |
 pT4 |  |  |  |  |  |  |
Lymph nodes | ||||||
 pN0 | 1.921 | 1.010–1.045 | 0.038 | 2.294 | 1.295–4.065 | 0.004 |
 pN1–pN3 |  |  |  |  |  |  |
 pNx |  |  |  |  |  |  |
pM | ||||||
 M0 | 11.48 | 1.399–90.427 | 0.023 | 7.378 | 0.936–58.136 | 0.058 |
 M1 |  |  |  |  |  |  |
Stage | ||||||
 I | 1.025 | 1.006–1.045 | 0.010 | 0.512 | 0.374–0.701 | < 0.0001 |
 II |  |  |  |  |  |  |
 III |  |  |  |  |  |  |
 IV |  |  |  |  |  |  |
Oestrogen receptor | ||||||
 Negative | 1.009 | 0.999–1.019 | 0.078 |  |  |  |
 Positive |  |  |  |  |  |  |
Progesterone receptor | ||||||
 Negative | 0.991 | 0.972–1.010 | 0.355 |  |  |  |
 Positive |  |  |  |  |  |  |
HER2 | ||||||
 Negative | 1.002 | 0.983–1.021 | 0.847 |  |  |  |
 Positive |  |  |  |  |  |  |
Molecular tumour types | ||||||
 Triple negative | 1.400 | 0.612–3.200 | 0.425 |  |  |  |
 Other types | ||||||
GAL3ST1 | ||||||
 Negative (0) | 0.595 | 0.354–0.999 | 0.046 | 0.604 | 0.351–1.038 | 0.068 |
 Positive (1–12) | ||||||
GAL3ST1 chemotherapy subgroup | ||||||
 Negative (0) | 0.659 | 0.388–1118 | 0.112 |  |  |  |
 Positive (1–12) |